Constrained Phenylalanine Derivatives by Enyne Metathesis and DielsϪAlder Reaction
FULL PAPER
Ethyl 2-Allyl-N-(diphenylmethylene)-2-propargylglycinate (20): A
stirred solution of n-tetrabutylammonium bromide (143 mg,
Ethyl
8-Acetamido-3,4-dihydro-5H-cyclopenta[e]-1,4-naphthoqui-
none-8-carboxylate (24): A solution of the diene 15 (25 mg,
0.44 mmol) and KOH (750 mg, 13.4 mmol) in dry acetonitrile 0.11 mmol), benzoquinone (12.1 mg, 0.11 mmol) and a catalytic
(15 mL) was added to a solution of 19 (1.365 g, 4.47 mmol) and
allyl bromide (812 mg, 6.71 mmol) in acetonitrile (10 mL) at 0 °C
over a period of 5 min. The reaction mixture was then stirred for
6 h at 0Ϫ10 °C. At the conclusion of the reaction (TLC mon-
itoring), the reaction mixture was filtered and concentrated, the
residue was taken up in ether (150 mL), and washed with water
and brine, dried over MgSO4 and concentrated. The residue was
purified on a flash alumina column (1:20, ethyl acetate/hexane) to
give 20 (1.2 g, 77%) as a colorless liquid. IR (neat): ν˜ ϭ 3300,
amount of hydroquinone (1 mg) in dry toluene (3 mL) was refluxed
for 2 days. The solvent was concentrated under reduced pressure
and the crude product was purified on a silica gel column with
ethyl acetate/hexane (2:3) as eluent to give the cycloadduct (34.4
mg, 93%) as a thick liquid. Subsequently, this adduct (20 mg,
0.06 mmol) and DDQ (13.4 mg, 0.05 mmol) were refluxed in tolu-
ene (3 mL) for 24 h. The solvent was then evaporated and the res-
idue was purified by flash column chromatography (silica gel, 1:5
ethyl acetate/hexane) to give 24 as a dark brown liquid (13.1 mg,
1731cmϪ1. Ϫ 1H NMR (300 MHz, CDCl3): δ ϭ 1.12 (t, J ϭ 67%). IR (neat): ν˜ ϭ 3296, 1732 cmϪ1. Ϫ 1H NMR (300 MHz,
7.2 Hz, 3 H), 1.9 (t, J ϭ 2.4 Hz, 1 H) 2.8Ϫ2.9 (m, 4 H), 3.75 (q, CDCl3) δ ϭ 1.23 (t, J ϭ 7.2 Hz, 3 H), 1.98 (s, 3 H), 3.53 (1/2 ABq,
J ϭ 7.2 Hz, 2 H), 5.1Ϫ5.2 (m, 2 H), 5.7Ϫ5.9 (m, 1 H), 7.1Ϫ7.8 (m, J ϭ 17.7 Hz, 1 H) 3.74 (1/2 ABq, J ϭ 17.7 Hz, 1 H), 3.82 (d, J ϭ
10 H).
2.7 Hz, 2 H), 4.22 (q, J ϭ 7.2 Hz, 2 H), 6.30 (s, 1 H), 6.92 (ABq,
J ϭ 10.5 Hz, 2 H), 7.56 (d, J ϭ 7.8 Hz,1 H) 8.01 (d, J ϭ 7.8 Hz, 1
H). Ϫ UV (CHCl3): λmax (ε, Ϫ1 cmϪ1) ϭ 250 (8.6 ϫ 103), 358
(2.06 ϫ 103). Ϫ EI-HRMS (C18H17NO5): calcd. 327.1106; found
327.1104.
Hydrolysis of the Enyne Building Block (20): To a solution of glycin-
ate 20 (700 mg, 2.02 mmol) in diethyl ether (15 mL) was added 1
HCl (3 mL). The reaction mixture was stirred at room temp. for
24 h. The ether layer was then discarded and the aqueous layer
basified with ammonia solution to pH ഠ 10. The reaction mixture
was then extracted with ethyl acetate. The combined organic ex-
tracts were washed with water and brine, dried over MgSO4 and
concentrated to give the amino ester as a light yellow oil (347 mg,
95%). IR (neat): ν˜ ϭ 3371, 2119, 1733 cmϪ1. Ϫ 1H NMR
(300 MHz, CDCl3): δ ϭ 1.20 (t, J ϭ 6.0 Hz, 3 H), 1.88 (br s, 2 H),
2.06 (t, J ϭ 2.7 Hz, 1 H), 2.31Ϫ2.70 (m, 4 H), 4.21 (q, J ϭ 7.2 Hz,
2 H), 5.01Ϫ5.23 (m, 2 H), 5.61Ϫ5.82 (m, 1 H).
Acknowledgments
We are thankful to DST, New Delhi for the financial support. N.
S and E. B thank CSIR, New Delhi for the award of Fellowships.
We also thank RSIC-Mumbai, TIFR & Dr. M. S. Nair for record-
ing the spectral data.
[1]
C. Cativiela, M. D. Diaz-de-Villegas, Tetrahedron: Asymmetry
Ethyl N-acetamido-(؎)2-allyl-4-pentynoate (16): To a solution of
the above amino ester (346 mg, 1.9 mmol) in dichloromethane
(20 mL) was added a catalytic amount of DMAP and acetic anhyd-
ride (520 mg, 5.0 mmol). The resulting reaction mixture was stirred
at room temp. for 8 h. Then, the reaction mixture was concentrated
and the residue was chromatographed on a silica gel column (1:5
ethyl acetate/hexane) to give crystalline product 16 (300 mg, 70%).
M.p. 90Ϫ91 °C. Ϫ IR (neat): ν˜ ϭ 3419 1735, 2121, 1647cmϪ1. Ϫ
1H NMR (300 MHz, CDCl3): δ ϭ 1.30 (t, J ϭ 7.2 Hz, 3 H), 1.96
(t, J ϭ 2.4 Hz, 1 H), 2.09 (s, 3 H), 2.49 (dd, J ϭ 7.5, 13.5 Hz, 1
H), 2.79 (d 1/2 ABq, J ϭ 2.7, 16.8 Hz, 1 H), 3.12 (dd, J ϭ 7.5,
13.5 Hz, 1 H), 3.34 (d 1/2 ABq, J ϭ 3.0, 17.1 Hz, 1 H), 4.26 (dq,
J ϭ 1.8, 5.4 Hz, 2 H), 5.07Ϫ5.15 (m, 2 H), 5.53 (m, 1 H), 6.35 (s,
1 H). Ϫ 13C NMR (75.43 MHz, CDCl3): δ ϭ 14.2, 23.8, 25.0, 39.0,
62.2, 62.7, 70.8, 79.3, 119.6, 131.5, 169.5, 171.8. Ϫ MS: m/z ϭ 223
[Mϩ]. Ϫ C12H17NO3 (223.27): calcd. C 64.53, H 7.67, N 6.27; found
C 64.31, H 7.41, N 6.01.
2000, 11, 645; S. E. Gibson, N. Guillo, M. J. Tozer, Tetrahedron
1999, 55, 585; A. Giannis, T. Kolter, Angew. Chem. Int. Ed.
Engl. 1993, 32, 1244; R. O. Duthaler, Tetrahedron 1997, 50,
1539; R. M. Williams, Synthesis of Optically Active α-Amino
Acids, Pergamon Press, Oxford, 1989; M. Goodman, H. Shao,
Pure Appl. Chem. 1996, 68, 1303; J. Gante, Angew. Chem. Int.
Ed. Engl. 1994, 33, 1699; R. M. J. Liskamp, Angew. Chem. Int.
Ed. Engl. 1994, 33, 305; C. E. Toniolo, Benedetti, ISI Atlas of
Science; Biochemistry 1988, 225.
[2]
E. Gavuzzo, G. Lucente, F. Mazza, G. P. Zecchini, M. P. Parad-
isi, G. Pochetti, I. Torrini, Int. J. Peptide. Protein. Res. 1991,
38, 268; I. Torrini, G. P. Zecchini, M. P. Paradisi, G. Lucente,
E. Gavuzzo, F. Mazza, G. Pochetti, S. Spisani, A. L. Giuliani,
Int. J. Peptide. Protein. Res. 1991, 38, 495.
[3]
H. Josien, S. Lavielle, A. Brunissen, M. Saffroy, Y. Torrens, J-
C. Beaujouan, J. Glowinski, G. Chassaing, J. Med. Chem. 1994,
37, 1586.
[4]
P. Balaram, Curr. Opin. Struct. Biol. 1992, 2, 845; C. L.
Wysong, T. S. Yokum, M. L. McLaughlin, R. P. Hammer.
ChemTech 1997, 26.
[5]
V. W. Cornish, P. G. Schultz, Curr. Opin. Struct. Biol. 1994,
Ethyl (؎)-1-Acetamido-3-cyclopentene-3-vinyl-1-carboxylate (15):
To a solution of the enyne building block 16 (200 mg, 0.86 mmol)
in CH2Cl2 (10 mL) was added GrubbsЈ catalyst [Cl2(PCy3)2Ruϭ
CHPh] (73 mg 0.086 mmol) (10 mol%) and the reaction mixture
was stirred at room temp. for 24 h under an argon atmosphere. The
reaction mixture was then concentrated under vacuum and purified
on a silica gel column by eluting with petroleum ether/ethyl acetate
(5:1) to give 15 (150 mg, 75%) as a crystalline product. M.p. 85Ϫ86
°C. Ϫ IR (neat): ν˜ ϭ 3296, 1732, 1663 cmϪ1. Ϫ 1H NMR
(300 MHz, CDCl3): δ ϭ 1.26 (t, J ϭ 7.2 Hz, 3 H), 1.98 (s, 3 H),
2.74 (dd, J ϭ 16.2, 16.7 Hz, 2 H), 3.17 (dd, J ϭ 16.5, 15.9 Hz, 2
H), 4.21 (q, J ϭ 7.2 Hz, 2 H), 5.04Ϫ5.12 (m, 2 H), 5.62 (s, 1 H)
6.10 (s, 1 H), 6.51 (dd, J ϭ 10.8, 17.4 Hz, 1 H). Ϫ 13C NMR
(75.43 MHz, CDCl3): δ ϭ 14.0, 22.9, 42.5, 44.3, 61.5, 64.1, 115.1,
126.5, 132.5, 140.1, 170.0, 173.4. Ϫ MS: m/z ϭ 223 [Mϩ]. Ϫ EI-
4, 601.
[6]
F. Trigalo, D. Buisson, R. Azerad, Tetrahedron Lett. 1988, 29,
6109.; A. Bhandari, D. G. Jones, J. R. Schulleck, K.Vo, C. A.
Schunk, L. L. Tamanaha, D.Chen, Z. Yuan, M. C. Needels,
M. A. Gallop, Bioorg. Med. Chem. Lett. 1998, 8, 2303 and
references cited therein.
[7]
G. L. Grunwald, S. H. Kuttab, M. A. Pleiss, J. B. Mangold, P.
Sione, J. Med. Chem. 1980, 23, 754.
[8] [8a]
S. Kotha, E. Brahmachary, J. Org. Chem. 2000, 65, 1359.
Ϫ
Ϫ
[8b] S. Kotha, N. Sreenivasachary, Chem. Commun. 2000, 503.
[8c]
S. Kotha, E. Brahmachary, Tetrahedron Lett. 1997, 38,
[8d]
3561. Ϫ
S. Kotha, E. Brahmachary, N. Sreenivasachary,
Tetrahedron Lett. 1998, 39, 4095.
[9]
C. R. Ganellin, Adv. Drug. Res, Vol 4, 163; B. Hong, S. Sarshar,
Org. Pre. Proc. Int. 1999, 31, 1.
S. Kotha, E. Brahmachary, Bioorg. & Med. Chem. Lett. 1997,
7, 2719 and references cited therein
A. Mazon, C. Najera, J. Ezequerra, C. Pedregal, Tetrahedron
Lett. 1995, 36, 7697; B. Møller, K. Undheim, Tetrahedron 1998,
54, 5789 and references cited therein.
[10]
[11]
HRMS (C10H12NO3 [M
194.0815.
Ϫ C2H5]): calcd. 194.0817; found
Eur. J. Org. Chem. 2001, 787Ϫ792
791